Life Healthcare Group Holdings Limited announced the appointments of Mr. Paul Moeketsi and Mr. Fulvio Tonelli as independent non- executive directors of the Board, with effect from 23 February 2023 and 1 April 2023 respectively. Paul is a qualified chartered accountant with over fifteen years of direct South African private equity experience. He is currently the Managing Partner of Sanlam Private Equity, a fund that manages over R4 billion in private equity assets.

His earlier experience include being a partner at Medu Capital where, in addition to his firm-wide responsibilities over nine years, he led and managed a number of high-profile mid-market investment initiatives. Paul was also an investment director at Value Capital Partners, a pioneer in bringing value-creation strategies to the investment process in the South African listed market. During this time, he led investments into Sun International, Metair and Grand Parade Investments.

Fulvio was, until the end of June 2019, the Chief Operating Officer and Partner at PwC Africa and a member of the firm's leadership team. In this role, he assisted in the delivery of the firm's overall strategy and was also responsible for the effective operation of the firm's risk management, finance, information technology and other internal services. His experience includes being the audit partner on many listed entities such as South African Breweries Ltd, Standard Bank Group Ltd, and the FirstRand Group Ltd. Fulvio joined PwC in July 1987 following completion of articles at Deloitte and retired from the firm in June 2020.

Fulvio is currently a non-executive director of the ABSA Group board, Equites Property Fund Limited, and The Ethics Institute of South Africa. He is also the chairperson of the Independent Regulatory Board for Auditors (IRBA). Board Committee changes With effect from the date of their appointments, Paul will serve on the Investment, Human Resources & Remuneration and Risk, Compliance & IT Governance Committees and Fulvio will serve on the Audit, Human Resources & Remuneration and Nominations & Governance Committees of the Company.

Lead Independent Director Peter Golesworthy will be stepping down as the Lead Independent Director of the Company with effect from 23 February 2023 and Advocate Mahlape Sello will be appointed as the Lead Independent Director for the Company, from this date. Mahlape Sello is a practising Advocate and a member of the Johannesburg Society of Advocates. She has been in practice since 2003.

She is a panellist with the Arbitration Foundation of Southern Africa and China-Africa Joint Arbitration Centre. Mahlape was appointed a member of the South African Law Reform Commission in 2007, on which she served until December 2011, and was then reappointed in August 2013 to 2016. She is a board member of Tiger Brands Limited and the former chairperson of Murray & Roberts Limited, having been appointed to the board in 2006 and to the chair in 2009.

She is the former chairperson of the Advertising Industry Tribunal Appeal Committee of the Advertising Standards Authority of South Africa (appointed in 2012 - 2018). The Chairman added: The Board acknowledges the exceptional guidance and support that has been provided by Peter Golesworthy as the Lead Independent Director and thanks him for his invaluable contribution during his tenure. Mahlape Sello is a valued member of the Board and her professionalism, expertise and candid contribution will hold her in exceptional stead as she takes on the role of Lead Independent Director.

Resignation from the Board Dr Malefetsane Ngatane has resigned as an independent non-executive director of the Board, with effect from 22 February 2023. Dr Ngatane has been with the Company prior to its listing in 2010 and his clinical expertise and measured contribution has been of great value to the Board. The Board wishes to thank Dr Ngatane for his dedicated service and outstanding contribution to the Board during his tenure and wishes him the very best during his well- deserved retirement.